Author(s): Gesselman AN; Bennett-Brown M; Dubé S; Kaufman EM; Campbell JT; Garcia JR;

Background: Research demonstrates significant gender- and sexual orientation-based differences in orgasm rates from sexual intercourse; however, this "orgasm gap" has not been studied with respect to age. Aim: The study sought to examine age-related disparities in orgasm rates from sexual intercourse by gender and sexual orientation. Methods: A survey s ...

Article GUID: 38957591

Author(s): Pfaus JG; Antonie RA; Dosa PI; Kim SW;

Rationale: Cabergoline (CAB) is an ergot derivative typically prescribed for the treatment of hyperprolactinemia. It suppresses the release of prolactin through agonist actions on dopamine (DA) D2 receptors; however, it possesses binding affinity for other DA and 5-HT receptors. Side effects that exacerbate valvular heart disease can occur with high doses ...

Article GUID: 37968530

Author(s): González Cautela BV; Quintana GR; Akerman J; Pfaus JG;

RATIONALE: Sexual side effects of chronic treatment with selective serotonin reuptake inhibitors (SSRIs) in humans include anorgasmia and loss of sexual desire and/or arousal which interferes with treatment compliance. There are few options at present to reduce these effects. Because orgasm and desire are mediated in part by activation of sympathetic arou ...

Article GUID: 33242109